Related Experiment Videos
[Sleep apnea syndrome and obesity]
1Service de Pneumologie, Hôtel-Dieu de Paris, 1, place du Parvis-Notre-Dame, 75181 Paris Cedex 04. j-pierre.laaban@htd.ap-hop-paris.fr
Revue De Pneumologie Clinique
|June 26, 2002
Summary
Obesity significantly increases the risk of sleep apnea syndrome (SAS). Weight loss, especially from surgery, can dramatically improve SAS, with nasal CPAP often being the most effective treatment for obese patients.
Area of Science:
- Cardiorespiratory Medicine
- Sleep Medicine
- Obesity Research
Context:
- Obesity is a primary risk factor for sleep apnea syndrome (SAS).
- SAS prevalence is notably high in individuals with massive and visceral obesity.
- The precise mechanisms linking obesity to obstructive sleep apneas are not fully understood, but increased upper airway collapsibility is a likely contributor.
Purpose:
- To explore the relationship between obesity and sleep apnea syndrome.
- To examine the impact of obesity on SAS severity and associated complications.
- To review the effectiveness of various treatments for SAS in obese individuals.
Summary:
- Obesity exacerbates SAS, leading to more frequent and severe cardiorespiratory complications like hypertension.
- Significant weight loss, particularly through bariatric surgery, often results in a marked reduction in the apnea-hypopnea index.
- Dietary weight loss shows variable improvement in SAS for moderately obese patients.
- Surgical interventions like pharyngoplasty and mandibular devices have limited success in massive obesity.
- Nasal continuous positive airway pressure (CPAP) is frequently the sole effective treatment for obese patients with SAS.
Impact:
- Highlights the critical role of weight management in mitigating SAS and its severe health consequences.
- Underscores the effectiveness of bariatric surgery and nasal CPAP in managing SAS in obese populations.
- Informs clinical practice regarding treatment selection for sleep apnea syndrome in the context of obesity.